Markets

Markets Overview Market Context

Briefs Calendar

Research

News Search AI Market Assistant Charts & News Instrument directory Macro Politics Prediction Markets News Archive

LIVECAST Markets

☀◐Theme

Menu

Home LIVECAST Markets Market Context Briefs Calendar News Search AI Market Assistant Charts & News Instrument directory Macro Politics Prediction Markets News Archive Account

Home News ArchiveGilead hits mid-stage trial success for oral bowel disease therapy

Live News NEWS FLASH L impact Oct 19, 2026, 02:19 PM UTC

Gilead hits mid-stage trial success for oral bowel disease therapy

SquawkNews Desk

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

No ticker tags on this item.

Related stories

Missile fired at Iranian Kurdish opposition camp northeast of Iraq's Erbil - Security Sources H impact | NEWS | Oct 21, 2026, 07:51 AM UTC Nickel Extends Gains Nickel traded around $16,000 per tonne, extending its rebound amid short-covering and prospects of coordinated production cuts in Indonesia. Major Chinese producers are expected to L impact | NEWS | Oct 21, 2026, 07:39 AM UTC The FTSE 100 Index Opens 0.21% Lower The FTSE 100 Index is losing 22 points. Losses were led by 3i (-5.29%), Aberdeen Group (-3.40%) and Kingfisher (-2.74%). Offsetting the fall, top gainers were Ithaca Energy (4.19%) L impact | NEWS | Oct 21, 2026, 07:32 AM UTC The DAX Index Opens 0.04% Higher The DAX Index is up by 11 points or 0.04 percent on Wednesday. Top gainers are Infineon (2.04%), Qiagen NV (1.70%) and RWE (1.33%). Biggest losses came from Volkswagen (-1.75%), Fr L impact | NEWS | Oct 21, 2026, 07:31 AM UTC The CAC 40 Index Opens 0.37% Higher The CAC 40 Index is gaining 29 points or 0.37 percent on Wednesday. Leading the gains are Essilor (11.96%), Legrand (2.36%) and Bureau Veritas (1.80%). Top losers are Carrefour (-1 L impact | NEWS | Oct 21, 2026, 07:30 AM UTC Moody's ratings upgrades TSMC's ratings to AA2; outlook stable. L impact | NEWS | Oct 21, 2026, 07:26 AM UTC

SQUAWK/NEWS

Independent financial newsroom. Editorial expertise and proprietary AI. Paid LiveCast brings live headlines, chart context and priority audio to your trading day. Free research tools remain available.

LiveCast passes from $15 · Institutional API access.

Start LiveCast

News & Research

Open LiveCast
Session Briefs
Market Context
Macro
Politics
Prediction Markets
News Archive

Markets & Tools

Charts & News
Markets Overview
US Stocks
Market Movers
Economic Calendar
Policy Calendar
AI Market Assistant
News Search
Instrument Directory

Guides

Charts & News Guide
How LiveCast Works
What Is an Audio Squawk?
Why News Moves Markets
News for Traders
How to Trade the News

Plans & API

Plans & Pricing
Institutional API
RSS Feed

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact us

© 2026 SquawkNews

Privacy Policy Terms of Use

SquawkNews publishes market information and context. It does not provide investment advice or trade recommendations.